Nucleic acids and proteins from streptococcus groups A and B
Details for Australian Patent Application No. 2002214127 (hide)
International Classifications
Event Publications
8 July 2004 Amendment Made
The nature of the amendment is: Amend the name of the applicant/patentee from Chiron Srl to Chiron S.r.l.
7 June 2007 Application Accepted
Published as AU-B-2002214127
4 October 2007 Standard Patent Sealed
5 February 2009 Alteration of Name
The name of the patentee has been altered to The Institute for Genomic Research; Novartis Vaccines and Diagnostics S.r.l.
18 February 2010 Assignment Registered
Novartis Vaccines and Diagnostics S.r.l.; The Institute for Genomic Research The patent has been assigned to Novartis Vaccines and Diagnostics S.r.l.; J. Craig Venter Institute ,Inc.
1 December 2011 Assignment Registered
J. Craig Venter Institute ,Inc.; Novartis Vaccines and Diagnostics S.r.l. The patent has been assigned to J. Craig Venter Institute, Inc.; Novartis Vaccines and Diagnostics, Inc. Assignments Registered
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional

- Editable Word format reports
- For IP Professionals
- Multiuser